EUVIMEDEUVIMED entdecken
Crossref

Evaluation of HIV-1 antiretroviral drug resistance profiles in the peripheral blood reservoir of successfully treated persons using massive sequencing and viral full genome characterization

Ornella M Botelho, Rossana P Basso, Luisa D Da Mota, Vanusa P Da Hora, Marianne M Garrido, Elizabeth S Machado, Brunna M Alves, Marcelo A Soares

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkad104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Ornella M Botelho und 7 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Genética e Virologia Tumoral, Instituto Nacional do Câncer, Rua André Cavalcanti, 37 - 4° andar, 20.231-050, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, HIV Seropositivity, Anti-HIV Agents. Die Arbeit nennt 83 Literaturangaben. Gefördert von: Brazilian Research Council, Merck Sharp & Dohme Avenir, Rio de Janeiro State Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antiretroviral therapy has revolutionized HIV treatment, increasing quality and life expectancy of people living with HIV (PLWH). However, the expansion of treatment has resulted in an increase in antiretroviral-resistant viruses, which can be an obstacle to maintenance of successful ART.

Objectives

This study analysed the genetic composition of the HIV near full-length genome (NFLG) from archived proviruses of PLWH under successful ART, and determined the presence/frequency of drug resistance mutations (DRMs) and viral subtype. Patients and methods Forty-six PLWH from Rio de Janeiro (RJ) and 40 from Rio Grande (RS) had proviral HIV NFLG PCR-amplified and ultradeep sequenced. The presence/frequency of DRMs were analysed in Geneious. Phylogenetic analyses were performed using PhyML and SimPlot.

Results

All samples included in the study were sequenced and 69 (80.2%) had the HIV NFLG determined. RJ and RS showed a predominance of HIV subtypes B (78.3%) and C (67.5%), respectively. Overall, 168 DRMs were found in 63 (73.3%) samples, and 105 (62.5%) of them were minority variants. Among DRMs, 41 (39.0%) minority variants and 33 (52.4%) variants with frequency above 20.0% in the viral population were able to confer some degree of resistance to at least one drug in use by respective patients, yet no one showed signs of therapeutic failure.

Conclusions

Our study contributes to the understanding of the impact of DRMs on successful therapy and supports the sustainability of combinatorial ART, because all patients maintained their successful treatment despite the high prevalence of DRMs at low (62.5%) or high (37.5%) frequency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsHIV SeropositivityAnti-HIV AgentsHumansPhylogenyBrazilAnti-Retroviral AgentsMutationProvirusesDrug Resistance, ViralGenotype

Substanzen

Anti-Retroviral AgentsAnti-HIV Agents

Autor:innen und Institutionen

  • Programa de Genética e Virologia Tumoral, Instituto Nacional do Câncer, Rua André Cavalcanti, 37 - 4° andar, 20.231-050, Rio de Janeiro, Brazil.
  • Hospital Universitário Dr. Miguel Riet Corrêa Jr., Universidade Federal do Rio Grande, Rio Grande, Brazil.
  • Faculdade de Medicina, Universidade Federal do Rio Grande, Rio Grande, Brazil.
  • Serviço de Infectologia, Hospital Federal de Ipanema, Rio de Janeiro, Brazil.
  • Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Departamento de Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Förderung

  • Brazilian Research Council
  • Merck Sharp & Dohme Avenir
  • Rio de Janeiro State Science Foundation

Zitieren

APA

Botelho, O. M., Basso, R. P., Da Mota, L. D., Da Hora, V. P., Garrido, M. M., Machado, E. S., Alves, B. M., & Soares, M. A. (2023). Evaluation of HIV-1 antiretroviral drug resistance profiles in the peripheral blood reservoir of successfully treated persons using massive sequencing and viral full genome characterization. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad104

Vancouver

Botelho OM, Basso RP, Da Mota LD, Da Hora VP, Garrido MM, Machado ES, et al. Evaluation of HIV-1 antiretroviral drug resistance profiles in the peripheral blood reservoir of successfully treated persons using massive sequencing and viral full genome characterization. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad104

BibTeX
@article{Botelho2023,
  author = {Botelho, Ornella M and Basso, Rossana P and Da Mota, Luisa D and Da Hora, Vanusa P and Garrido, Marianne M and Machado, Elizabeth S and Alves, Brunna M and Soares, Marcelo A},
  title = {Evaluation of HIV-1 antiretroviral drug resistance profiles in the peripheral blood reservoir of successfully treated persons using massive sequencing and viral full genome characterization},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkad104}
}
Kostenlos starten →